TGR-1202 R-enantiomer

CAS No. 1532533-69-9

TGR-1202 R-enantiomer ( RP5264 R-enantiomer;TGR1202 R-enantiomer )

Catalog No. M12155 CAS No. 1532533-69-9

TGR-1202 R-enantiomer is is the less active enantiomer of TGR-1202 (Umbralisib), TGR-1202 is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 311 Get Quote
5MG 525 Get Quote
10MG 752 Get Quote
25MG 1143 Get Quote
50MG 1521 Get Quote
100MG 2061 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TGR-1202 R-enantiomer
  • Note
    Research use only, not for human use.
  • Brief Description
    TGR-1202 R-enantiomer is is the less active enantiomer of TGR-1202 (Umbralisib), TGR-1202 is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.
  • Description
    TGR-1202 R-enantiomer is is the less active enantiomer of TGR-1202 (Umbralisib), TGR-1202 is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.
  • Synonyms
    RP5264 R-enantiomer;TGR1202 R-enantiomer
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    1532533-69-9
  • Formula Weight
    571.55
  • Molecular Formula
    C31H24F3N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C1C(C2=CC=CC(F)=C2)=C([C@@H](C)N3N=C(C4=CC=C(OC(C)C)C(F)=C4)C5=C(N)N=CN=C53)OC6=CC=C(F)C=C16
  • Chemical Name
    4H-1-Benzopyran-4-one, 2-[(1R)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Locatelli SL, et al. Leukemia. 2016 Dec;30(12):2402-2405.
2. Deng C, et al. Blood. 2017 Jan 5;129(1):88-99.
3. Burris HA 3rd, et al. Lancet Oncol. 2018 Feb 20. pii: S1470-2045(18)30082-2.
4. Lampson BL, et al. Expert Opin Investig Drugs. 2017 Nov;26(11):1267-1279.
molnova catalog
related products
  • BAY 80-6946

    BAY 80-6946 (Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3Kα/β with IC50 of 0.469 nM/3.72 nM. Phase 2.

  • LY3023414

    LY3023414 is a potent, dual PI3K/mTOR inhibitor.

  • TASP0415914

    TASP0415914 is an orally potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ).